Healx AI-powered and patient-inspired. We accelerate the discovery of rare disease treatments.

Will you be at AI Driven Drug Discovery Summit in Boston on the 16 - 17 August? We will be! ๐Ÿ‘‹Our Chief Scientific Office...
03/08/2022

Will you be at AI Driven Drug Discovery Summit in Boston on the 16 - 17 August? We will be! ๐Ÿ‘‹

Our Chief Scientific Officer, Neil Thompson, will be talking about how we:

๐Ÿค– Leverage AI and omics technologies to identify potential therapies for rare diseases
๐Ÿงฌ Use comprehensive target activity profiles of drugs to optimise drug candidates
๐Ÿ’Š Identify combination therapies to deliver a greater impact to patients in need

Check out the rest of the agenda and register here ๐Ÿ‘‰

Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The inaugural AI Driven Drug Discovery Summit will highlight key approaches to implementing nove...

How do you translate academic breakthroughs into real-world impact for rare disease patients? ๐Ÿš€That's exactly what Bruce...
28/07/2022

How do you translate academic breakthroughs into real-world impact for rare disease patients? ๐Ÿš€

That's exactly what Bruce Bloom and Clara Tang from the Healx team discussed last week in IN-PART's webinar on 'Models of Open Innovation'.

Check it out here ๐Ÿ‘‡

We are 'In conversation with Healx' to discuss their strategies to find next-generation research for their R&D pipeline

Today is  ๐ŸŽ—๏ธFragile X is a rare neurodevelopmental condition and the most common genetic cause of learning difficulties ...
22/07/2022

Today is ๐ŸŽ—๏ธ

Fragile X is a rare neurodevelopmental condition and the most common genetic cause of learning difficulties in the world, but there are currently no effective or approved therapies available.

World Fragile X Day, a global initiative of the FRAXA Research Foundation, celebrates the families impacted by fragile X and highlights new treatment research. 355 landmarks will also be illuminated around the world to shine light on the syndrome.

We're proud to be working with the fragile X community to develop novel treatments and get them to patients in need. More information on our clinical trial here: https://healx.io/impact-fxs/

Help raise awareness of the condition by sharing our infographic ๐Ÿ‘‡

The NFXF International Fragile X Conference has now come to a close! Our team had a jam-packed 4 days of talks and prese...
19/07/2022

The NFXF International Fragile X Conference has now come to a close! Our team had a jam-packed 4 days of talks and presentations, while getting to meet patients, caregivers and family members living with fragile X.

It was great to share our data on AI-predicted therapies for fragile X syndrome. Learn more here ๐Ÿ‘‰ https://lnkd.in/ebnKDScm

Huge thanks to The National Fragile X Foundation for organising such an amazing event!

Cambridge, UK โ€“ July 20, 2022. Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare diseases, shared promising data about several AI-predicted candidates for the management of fragile X syndrome (FXS) in a poster and oral presentation...

We're expanding ๐Ÿ”ฌOur new lab at Chesterford Research Park will support our growing portfolio of disease projects and hel...
14/07/2022

We're expanding ๐Ÿ”ฌ

Our new lab at Chesterford Research Park will support our growing portfolio of disease projects and help fuel our AI platform with new proprietary data types.

Learn more here ๐Ÿ‘‡
https://healx.io/healx-opens-new-labs/

Cambridge, UK โ€“ July 12 2022: Chesterford Research Park is delighted to welcome Healx to the Parkโ€™s prestigious Science Village. Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare diseases, is taking more than 3,500 sq ft of space...

Weโ€™re excited to announce that recruitment has started for our IMPACT-FXS study at Rush University Medical Center and UM...
24/06/2022

Weโ€™re excited to announce that recruitment has started for our IMPACT-FXS study at Rush University Medical Center and UMass Chan Medical School, with more sites opening in the coming weeks. ๐ŸŽ‰

The Phase 2 trial will investigate the efficacy and safety of several potential medications for fragile X syndrome - the most common inherited cause of learning disability in the world. ๐Ÿงฌ

Learn more here:

Share this story Healx on Facebook Healx on Twitter

Tickets are now available for the Beacon for Rare Diseases Cambridge Rare Disease Showcase!This event will celebrate the...
08/06/2022

Tickets are now available for the Beacon for Rare Diseases Cambridge Rare Disease Showcase!

This event will celebrate the innovative rare disease projects taking place across Cambridge and the wider world.

Where: The Clayton Hotel, Cambridge
When: 6th July from 6:30 to 9:00pm.

We're very much looking forward to attending!

Join the rare community at the Clayton Hotel in Cambridge to hear rare disease stories and network. Register now to form connections and collaborations!

Policy plays a critical role in the development of rare disease treatments. ๐ŸงฌIn this op-ed for The Rare Disease Company ...
27/05/2022

Policy plays a critical role in the development of rare disease treatments. ๐Ÿงฌ

In this op-ed for The Rare Disease Company Coalition, our Chief Scientific Officer, Neil Thompson, explores why technological advances in the drug discovery and development space must be matched with progressive policy if we are to address the huge unmet need of rare disease patients.

Check it out here ๐Ÿ‘‡

Indeed, AI and other new approaches are allowing novel treatments to be designed, developed and delivered more quickly and on a scale never before seen in the industry. This is offering hope to millions of patients in need - particularly those living with a rare condition (95% of which still lack an...

Let's  . ๐ŸŒŽ It affects 1 in 3,000 people globally๐Ÿงฌ Is a lifelong condition that affects all populations equally, regardle...
17/05/2022

Let's .

๐ŸŒŽ It affects 1 in 3,000 people globally

๐Ÿงฌ Is a lifelong condition that affects all populations equally, regardless of gender or ethnicity

๐Ÿ’Š And treatments options are limited

This is why we are working on developing new treatments for NF1 in partnership with the Children's Tumor Foundation.

Today is NF Awareness Day, a time for members of the NF community to harness their power to drive awareness and support research that will lead to effective treatments for neurofibromatosis (NF).

Learn how you can get involved here

Neurofibromatosis, or NF, occurs in 1 of every 3,000 people, affecting more than 2.5 million people around the world. So why donโ€™t more people know about it?

Learn more about Angelman syndrome with our handy infographic about the rare disease. You can also download it here ๐Ÿ‘‰ ht...
21/04/2022

Learn more about Angelman syndrome with our handy infographic about the rare disease.

You can also download it here ๐Ÿ‘‰https://healx.io/wp.../uploads/2022/02/Angelman-infog.pdf

Is there a rare disease you'd want us to build an infographic for? Let us know in the comments!

08/04/2022

Hey there ๐Ÿ‘‹

Weโ€™re OOO today for Healxโ€™s Recharge Day ๐Ÿ”‹

In recognition of Stress Awareness Month, and in celebration of the incredible work the team has been doing, weโ€™re taking a company-wide holiday to switch off and focus on activities that support our mental and physical wellbeing. That means no emails, no meetings, no Slack - just time to do the things that make us happy.

See you next week!

From,

Team Healx

Address

Charter House, 66-68 Hills Road
Cambridge
CB21LA

Alerts

Be the first to know and let us send you an email when Healx posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share